Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China flag China · Delayed Price · Currency is CNY
22.97
-0.30 (-1.29%)
Mar 26, 2026, 11:30 AM CST

SHA:600332 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
36,04639,68943,71644,55046,35552,103
Market Cap Growth
-12.15%-9.21%-1.87%-3.90%-11.03%16.71%
Enterprise Value
30,15439,53342,08338,61438,37740,977
Last Close Price
23.2725.7427.5726.6927.1830.52
PE Ratio
12.6813.3115.4210.9911.6914.01
Forward PE
12.1212.9713.1110.4712.6114.55
PS Ratio
0.460.510.580.590.660.76
PB Ratio
0.900.991.161.221.381.66
P/TBV Ratio
1.071.181.361.431.622.03
P/FCF Ratio
--18.8918.008.2611.79
P/OCF Ratio
--12.7010.866.629.18
PEG Ratio
2.543.583.583.583.583.58
EV/Sales Ratio
0.390.510.560.510.540.59
EV/EBITDA Ratio
7.4110.299.727.077.679.33
EV/EBIT Ratio
9.4212.3411.398.058.5510.32
EV/FCF Ratio
-20.48-18.1815.606.849.27
Debt / Equity Ratio
0.390.390.370.330.360.32
Debt / EBITDA Ratio
3.843.843.042.092.302.14
Debt / FCF Ratio
--6.014.832.142.25
Net Debt / Equity Ratio
-0.20-0.20-0.23-0.28-0.38-0.40
Net Debt / EBITDA Ratio
-2.13-2.13-2.04-1.85-2.53-2.84
Net Debt / FCF Ratio
5.565.56-3.81-4.08-2.25-2.82
Asset Turnover
0.940.940.940.991.011.10
Inventory Turnover
5.025.025.145.535.455.53
Quick Ratio
1.171.171.111.171.201.27
Current Ratio
1.571.571.481.551.531.64
Return on Equity (ROE)
7.86%7.86%8.06%12.12%13.09%13.33%
Return on Assets (ROA)
2.41%2.41%2.88%3.91%3.98%3.94%
Return on Invested Capital (ROIC)
7.63%8.73%11.07%16.80%18.98%17.98%
Return on Capital Employed (ROCE)
7.10%7.10%8.60%11.30%12.00%11.70%
Earnings Yield
8.28%7.52%6.49%9.10%8.56%7.14%
FCF Yield
-4.08%-3.71%5.29%5.56%12.11%8.48%
Dividend Yield
3.88%3.30%2.90%2.81%2.69%2.25%
Payout Ratio
55.23%55.23%79.38%39.09%37.58%34.03%
Buyback Yield / Dilution
0.01%0.01%-0.02%0.02%--
Total Shareholder Return
3.91%3.31%2.88%2.82%2.69%2.25%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.